Dimethyl fumarate suppresses granulocyte macrophage colony-stimulating factor–producing Th1 cells in CNS neuroinflammation
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received November 19, 2019
- Accepted in final form March 2, 2020
- First Published May 5, 2020.
Author Disclosures
- Farinaz Safavi, MD, PhD,
- Rodolfo Thome, PhD,
- Zichen Li, MSc,
- Guang-Xian Zhang, MD, PhD and
- Abdolmohamad Rostami, MD, PhD
- Farinaz Safavi, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rodolfo Thome, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Zichen Li, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Guang-Xian Zhang, MD, PhD and
NONE
NONE
NONE
Scientific Reports, editor for 4 years
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH R01 NS099594-01. Zhang, G-X, (PI) 06/01/2017 Â 05/31/2022 Ursolic acid: a novel oral therapy for chronic stage of MS/EAE by both immunomodulation and neural repair. Award amount: $1,950,000 NIH R21 AI135601. Zhang, G-X, (PI) 06/01/2018 Â 05/31/2020 P7C3 as a novel immunomodulator for CNS autoimmunity Award amount: $429,000
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Abdolmohamad Rostami, MD, PhD
NONE
NONE
NONE
(1) Journal of Neurological Sciences, Member of Editorial Board, 15 years. (2) Multiple Sclerosis Journal, Member of the Editorial Board, 10 years.
1. Use of BBI in Multiple Sclerosis.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) National Institutes of Health, R01AI106026, PI, 5 years. (2) National Institutes of Health, R01NS0088729, PI, 5 years.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (F.S., R.T., Z.L., G.-X.Z., A.R.), Thomas Jefferson University, Philadelphia, PA. Dr. Safavi is now at National Institute of Health, NINDS, Bethesda, MD.
- Correspondence
Dr. Rostami a.m.rostami{at}jefferson.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.